1-11 of 11
Tomio Onuma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39: 455–464

Tomoya Mita, Naoto Katakami, Toshihiko Shiraiwa, Hidenori Yoshii, Tomio Onuma, Nobuichi Kuribayashi, Takeshi Osonoi, Hideaki Kaneto, Keisuke Kosugi, Yutaka Umayahara, Tsunehiko Yamamoto, Kazunari Matsumoto, Hiroki Yokoyama, Mamiko Tsugawa, Masahiko Gosho, Iichiro Shimomura, Hirotaka Watada, on behalf of the Collaborators on the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) Trial
Journal: Diabetes Care
Diabetes Care 2017;40(6):808
https://doi.org/10.2337/dc17-er06a
Published: 18 April 2017
View article titled, Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39: 455–464
Open the PDF for Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39: 455–464 in another window
Journal Articles

Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39: 139–148

Tomoya Mita, Naoto Katakami, Hidenori Yoshii, Tomio Onuma, Hideaki Kaneto, Takeshi Osonoi, Toshihiko Shiraiwa, Keisuke Kosugi, Yutaka Umayahara, Tsunehiko Yamamoto, Hiroki Yokoyama, Nobuichi Kuribayashi, Hideaki Jinnouchi, Masahiko Gosho, Iichiro Shimomura, Hirotaka Watada, on behalf of the Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Trial
Journal: Diabetes Care
Diabetes Care 2017;40(6):808
https://doi.org/10.2337/dc17-er06b
Published: 18 April 2017
View article titled, Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39: 139–148
Open the PDF for Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39: 139–148 in another window
Journal Articles

Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial

Tomoya Mita, Naoto Katakami, Toshihiko Shiraiwa, Hidenori Yoshii, Tomio Onuma, Nobuichi Kuribayashi, Takeshi Osonoi, Hideaki Kaneto, Keisuke Kosugi, Yutaka Umayahara, Tsunehiko Yamamoto, Kazunari Matsumoto, Hiroki Yokoyama, Mamiko Tsugawa, Masahiko Gosho, Iichiro Shimomura, Hirotaka Watada, on behalf of the Collaborators on the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE) Trial
Journal: Diabetes Care
Diabetes Care 2016;39(3):455–464
https://doi.org/10.2337/dc15-2145
Published: 28 January 2016
View article titled, Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): <subtitle>A Randomized Controlled Trial</subtitle>
Open the PDF for Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): <subtitle>A Randomized Controlled Trial</subtitle> in another window
Includes: Supplementary data
Journal Articles

Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)

Tomoya Mita, Naoto Katakami, Hidenori Yoshii, Tomio Onuma, Hideaki Kaneto, Takeshi Osonoi, Toshihiko Shiraiwa, Keisuke Kosugi, Yutaka Umayahara, Tsunehiko Yamamoto, Hiroki Yokoyama, Nobuichi Kuribayashi, Hideaki Jinnouchi, Masahiko Gosho, Iichiro Shimomura, Hirotaka Watada
Journal: Diabetes Care
Diabetes Care 2016;39(1):139–148
https://doi.org/10.2337/dc15-0781
Published: 01 December 2015
View article titled, Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)
Open the PDF for Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) in another window
Includes: Supplementary data
Journal Articles

Response to Ostberg and Hurel

Naomi Mitsuhashi, MD, Tomio Onuma, MD, Ryuzo Kawamori, MD
Journal: Diabetes Care
Diabetes Care 2003;26(3):961–962
https://doi.org/10.2337/diacare.26.3.961-a
Published: 01 March 2003
View article titled, Response to Ostberg and Hurel
Open the PDF for Response to Ostberg and Hurel in another window
Journal Articles

RANTES Promoter Genotype Is Associated With Diabetic Nephropathy in Type 2 Diabetic Subjects

Kunihiro Nakajima, MD, Yasushi Tanaka, MD, Takashi Nomiyama, MD, Takeshi Ogihara, MD, Fuki Ikeda, MD, Rei Kanno, MD, Noseki Iwashita, MD, Ken Sakai, MD, Hirotaka Watada, MD, Tomio Onuma, MD, Ryuzo Kawamori, MD
Journal: Diabetes Care
Diabetes Care 2003;26(3):892–898
https://doi.org/10.2337/diacare.26.3.892
Published: 01 March 2003
View article titled, RANTES Promoter Genotype Is Associated With Diabetic Nephropathy in Type 2 Diabetic Subjects
Open the PDF for RANTES Promoter Genotype Is Associated With Diabetic Nephropathy in Type 2 Diabetic Subjects in another window
Journal Articles

Coronary Artery Disease and Carotid Artery Intima-Media Thickness in Japanese Type 2 Diabetic Patients

Naomi Mitsuhashi, MD, Tomio Onuma, MD, Sayaka Kubo, MD, Naoko Takayanagi, MD, Motoe Honda, MD, Ryuzo Kawamori, MD
Journal: Diabetes Care
Diabetes Care 2002;25(8):1308–1312
https://doi.org/10.2337/diacare.25.8.1308
Published: 01 August 2002
View article titled, Coronary Artery Disease and Carotid Artery Intima-Media Thickness in Japanese Type 2 Diabetic Patients
Open the PDF for Coronary Artery Disease and Carotid Artery Intima-Media Thickness in Japanese Type 2 Diabetic Patients in another window
Journal Articles

Usefulness of Revised Fasting Plasma Glucose Criterion and Characteristics of the Insulin Response to an Oral Glucose Load in Newly Diagnosed Japanese Diabetic Subjects

Yasushi Tanaka, MD, Yoshihito Atsumi, MD, Takayuki Asahina, MD, Kazuhiro Hosokawa, MD, Kenpei Matsuoka, MD, Junichiro Kinoshita, MD, Tomio Onuma, MD, Ryuzo Kawamori
Journal: Diabetes Care
Diabetes Care 1998;21(7):1133–1137
https://doi.org/10.2337/diacare.21.7.1133
Published: 01 July 1998
View article titled, Usefulness of Revised Fasting Plasma Glucose Criterion and Characteristics of the Insulin Response to an Oral Glucose Load in Newly Diagnosed Japanese Diabetic Subjects
Open the PDF for Usefulness of Revised Fasting Plasma Glucose Criterion and Characteristics of the Insulin Response to an Oral Glucose Load in Newly Diagnosed Japanese Diabetic Subjects in another window
Journal Articles

Role of Glycemic Control and Blood Pressure in the Development and Progression of Nephropathy in Elderly Japanese NIDDM Patients

Yasushi Tanaka, MD, Yoshihito Atsumi, MD, Kenpei Matsuoka, MD, Tomio Onuma, MD, Toshio Tohjima, MD, Ryuzo Kawamori, MD
Journal: Diabetes Care
Diabetes Care 1998;21(1):116–120
https://doi.org/10.2337/diacare.21.1.116
Published: 01 January 1998
View article titled, Role of Glycemic Control and Blood Pressure in the Development and Progression of Nephropathy in Elderly Japanese NIDDM Patients
Open the PDF for Role of Glycemic Control and Blood Pressure in the Development and Progression of Nephropathy in Elderly Japanese NIDDM Patients in another window
Journal Articles

Different Change in Lipoprotein(a) Levels From Lipid Levels of Other Lipoproteins With Improved Glycemie Control in Patients With NIDDM

Toru Kikuchi, MD, Tomio Onuma, MD, Michitaka Shimura, MD, Masahiro Tsutsui, MD, Akitoshi Boku, MD, Jun Matsui, MD, Kazuo Takebe, MD
Journal: Diabetes Care
Diabetes Care 1994;17(9):1059–1061
https://doi.org/10.2337/diacare.17.9.1059
Published: 01 September 1994
View article titled, Different Change in Lipoprotein(a) Levels From Lipid Levels of Other Lipoproteins With Improved Glycemie Control in Patients With NIDDM
Open the PDF for Different Change in Lipoprotein(a) Levels From Lipid Levels of Other Lipoproteins With Improved Glycemie Control in Patients With NIDDM in another window
Journal Articles

Altered Postprandial Insulin Requirement in IDDM Patients With Gastroparesis

Masataka Ishii, MD, Teruo Nakamura, MD, Fukio Kasai, MD, Tomio Onuma, MD, Tsuneharu Baba, MD, Kazuo Takebe, MD
Journal: Diabetes Care
Diabetes Care 1994;17(8):901–903
https://doi.org/10.2337/diacare.17.8.901
Published: 01 August 1994
View article titled, Altered Postprandial Insulin Requirement in IDDM Patients With Gastroparesis
Open the PDF for Altered Postprandial Insulin Requirement in IDDM Patients With Gastroparesis in another window